• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过微小RNA谱分析对不确定黑素细胞性病变进行分类

Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.

作者信息

Latchana Nicholas, Del Campo Sara E Martin, Grignol Valerie P, Clark Jennifer R, Albert Scott P, Zhang Jie, Wei Lai, Aldrink Jennifer H, Nicol Kathleen K, Ranalli Mark A, Peters Sara B, Gru Alejandro, Trihka Prashant, Payne Philip R O, Howard J Harrison, Carson William E

机构信息

Department of Surgery, The Ohio State University, Columbus, OH, USA.

Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Ann Surg Oncol. 2017 Feb;24(2):347-354. doi: 10.1245/s10434-016-5476-9. Epub 2016 Jul 28.

DOI:10.1245/s10434-016-5476-9
PMID:27469124
Abstract

PURPOSE

Identification of indeterminate melanocytic skin lesions capable of neoplastic progression is suboptimal and may potentially result in unnecessary morbidity from surgery. MicroRNAs (miRs) may be useful in classifying indeterminate Spitz tumors as having high or low risk for malignant behavior.

METHODS

RNA was extracted from paraffin-embedded tissues of benign nevi, benign Spitz tumors, indeterminate Spitz tumors, and Spitzoid melanomas in adults (n = 62) and children (n = 28). The expression profile of 12 miRs in adults (6 miRs in children) was analyzed by real-time polymerase chain reaction.

RESULTS

Benign Spitz lesions were characterized by decreased expression of miR-125b and miR-211, and upregulation of miR-22, compared with benign nevi (p < 0.05). A comparison of Spitzoid melanomas to benign nevi revealed overexpression of miR-21, miR-150, and miR-155 in the malignant primaries (p < 0.05). In adults, Spitzoid melanomas exhibited upregulation of miR-21, miR-150, and miR-155 compared with indeterminate Spitz lesions. Indeterminate Spitz lesions with low-risk pathologic features had lower miR-21 and miR-155 expression compared with Spitzoid melanoma tumors in adults (p < 0.05), while pathologic high-risk indeterminate Spitz lesions had increased levels of miR-200c expression compared with low-risk indeterminate lesions (p < 0.05). Pediatric Spitzoid melanomas exhibited increased miR-21 expression compared with indeterminate Spitz lesions (p < 0.05). Moreover, miR-155 expression was increased in indeterminate lesions with mitotic counts >1 and depth of invasion >1 mm, suggesting miR-155 expression is associated with histological characteristics.

CONCLUSIONS

miR expression profiles can be measured in indeterminate Spitz tumors and correlate with markers of malignant potential.

摘要

目的

对可能发生肿瘤进展的不确定黑素细胞性皮肤病变进行识别的效果欠佳,可能会导致不必要的手术相关发病率。微小RNA(miR)可能有助于将不确定的Spitz肿瘤分类为具有高或低恶性行为风险。

方法

从成人(n = 62)和儿童(n = 28)的良性痣、良性Spitz肿瘤、不确定的Spitz肿瘤和Spitz样黑色素瘤的石蜡包埋组织中提取RNA。通过实时聚合酶链反应分析12种miR在成人中的表达谱(儿童中为6种miR)。

结果

与良性痣相比,良性Spitz病变的特征是miR-125b和miR-211表达降低,miR-22上调(p < 0.05)。Spitz样黑色素瘤与良性痣的比较显示,恶性原发灶中miR-21、miR-150和miR-155过表达(p < 0.05)。在成人中,Spitz样黑色素瘤与不确定的Spitz病变相比,miR-21、miR-150和miR-155上调。具有低风险病理特征的不确定Spitz病变与成人Spitz样黑色素瘤肿瘤相比,miR-21和miR-155表达较低(p < 0.05),而病理高风险的不确定Spitz病变与低风险不确定病变相比,miR-200c表达水平升高(p < 0.05)。儿童Spitz样黑色素瘤与不确定的Spitz病变相比,miR-21表达增加(p < 0.05)。此外,有丝分裂计数>1且浸润深度>1 mm的不确定病变中miR-155表达增加,提示miR-155表达与组织学特征相关。

结论

可在不确定的Spitz肿瘤中测量miR表达谱,且其与恶性潜能标志物相关。

相似文献

1
Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.通过微小RNA谱分析对不确定黑素细胞性病变进行分类
Ann Surg Oncol. 2017 Feb;24(2):347-354. doi: 10.1245/s10434-016-5476-9. Epub 2016 Jul 28.
2
Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.用于黑素细胞性斯皮茨瘤诊断评估的全球微小RNA谱分析
J Surg Res. 2016 Oct;205(2):350-358. doi: 10.1016/j.jss.2016.06.085. Epub 2016 Jul 4.
3
p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.p16 表达:儿童恶性黑色素瘤与 Spitz 痣的分化标志物。
J Am Acad Dermatol. 2011 Aug;65(2):357-363. doi: 10.1016/j.jaad.2010.07.031. Epub 2011 May 6.
4
Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.B-RAF、N-RAS和H-RAS基因变异分析在Spitz痣和Spitzoid黑色素瘤鉴别诊断中的应用
Am J Surg Pathol. 2005 Sep;29(9):1145-51. doi: 10.1097/01.pas.0000157749.18591.9e.
5
Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.一系列Spitz样黑素细胞性病变中p16表达缺失及CDKN2A的拷贝数变化
Hum Pathol. 2016 Dec;58:152-160. doi: 10.1016/j.humpath.2016.07.029. Epub 2016 Aug 26.
6
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors.遗传和甲基化特征可区分良性、恶性和 Spitz 样黑色素细胞瘤。
Int J Cancer. 2022 Nov 1;151(9):1542-1554. doi: 10.1002/ijc.34187. Epub 2022 Jul 11.
7
Atypical Spitz Tumors: A Diagnostic Challenge.非典型斯皮茨瘤:一项诊断挑战。
Arch Pathol Lab Med. 2015 Oct;139(10):1263-70. doi: 10.5858/arpa.2015-0207-RA.
8
The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.Spitz 痣和传统(非 Spitz 样)黑色素瘤的免疫组织化学特征:一项基线研究。
Mod Pathol. 2010 Sep;23(9):1215-24. doi: 10.1038/modpathol.2010.102. Epub 2010 Jun 11.
9
Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.Spitz样黑素细胞肿瘤中的基因组畸变及其对诊断、预后和治疗的意义。
Pathology. 2016 Feb;48(2):113-31. doi: 10.1016/j.pathol.2015.12.007. Epub 2016 Jan 18.
10
Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.仅p16的表达无法区分Spitz痣和Spitz样黑色素瘤。
J Cutan Pathol. 2012 Dec;39(12):1062-74. doi: 10.1111/cup.12014. Epub 2012 Sep 25.

引用本文的文献

1
Diagnostic Algorithm to Subclassify Atypical Spitzoid Tumors in Low and High Risk According to Their Methylation Status.根据甲基化状态对低危和高危非典型 Spitz 样肿瘤进行亚型分类的诊断算法。
Int J Mol Sci. 2023 Dec 25;25(1):318. doi: 10.3390/ijms25010318.
2
Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.妇科部位起源的黑色素瘤中 microRNAs 及其靶基因的表达。
PLoS One. 2023 Jun 29;18(6):e0285804. doi: 10.1371/journal.pone.0285804. eCollection 2023.
3
MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma.
微小RNA-155与皮肤黑色素瘤中疾病相关免疫组化参数
Diagnostics (Basel). 2023 Mar 22;13(6):1205. doi: 10.3390/diagnostics13061205.
4
MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors.富含MicroRNA-21的外泌体作为黑色素瘤发生和进展中的表观遗传调节因子:西方生活方式因素的影响
Cancers (Basel). 2020 Jul 29;12(8):2111. doi: 10.3390/cancers12082111.
5
MicroRNA Ratios Distinguish Melanomas from Nevi.miRNA 比值可区分黑素瘤与痣。
J Invest Dermatol. 2020 Jan;140(1):164-173.e7. doi: 10.1016/j.jid.2019.06.126. Epub 2019 Sep 30.
6
MicroRNA heterogeneity in melanoma progression.黑色素瘤进展中的 miRNA 异质性。
Semin Cancer Biol. 2019 Dec;59:208-220. doi: 10.1016/j.semcancer.2019.05.021. Epub 2019 Jun 1.
7
Genomic Landscape of Spitzoid Neoplasms Impacting Patient Management.影响患者管理的Spitzoid肿瘤的基因组格局
Front Med (Lausanne). 2018 Dec 13;5:344. doi: 10.3389/fmed.2018.00344. eCollection 2018.